Article
USP20 as a super-enhancer-regulated gene drives T-ALL progression via HIF1A deubiquitination
5 Jul 2025
Abstract excerpt
T-cell acute lymphoblastic leukemia (T-ALL) is a highly aggressive hematologic malignancy with a poor prognosis, despite advancements in treatment. Many patients struggle with relapse or refractory disease. Investigating the role of the super-enhancer (SE) regulated gene ubiquitin-specific protease 20 ( USP20 ) in T-ALL could enhance targeted therapies and improve clinical outcomes. Analysis of histone H3 lysine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
